• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Boeing, PriceSmart And 80 Biggest Movers From Yesterday

    7/13/22 4:59:07 AM ET
    $AAL
    $ADIL
    $AERC
    $AKAN
    Air Freight/Delivery Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAL alert in real time by email

    Gainers

    • Sharps Compliance Corp. (NASDAQ:SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.
    • Canoo Inc. (NASDAQ:GOEV) shares climbed 53.2% to close at $3.63 after Walmart signed a definitive agreement with the company to purchase 4,500 all-electric delivery vehicles, beginning with the Lifestyle Delivery Vehicle, with the option to purchase up to 10,000 units.
    • Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) jumped 42.2% to close at $6.67 after the company announced positive interim results from a Phase 2 clinical trial evaluating setmelanotide for the treatment of severe obesity and hyperphagia in people living with hypothalamic obesity.
    • Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares jumped 39% to close at $11.98. The FDA has removed the clinical hold on Greenwich LifeSciences’ Flamingo-01 Phase 3 trial of GP2, immunotherapy to prevent breast cancer recurrences.
    • Regional Health Properties, Inc. (NYSE:RHE) gained 36.9% to close at $3.73.
    • China Online Education Group (NYSE:COE) jumped 32.8% to settle at $1.6074. China Online Education Group, last month, reported a first-quarter FY22 revenue decline of 89.7% year-on-year to $9.5 million.
    • Histogen Inc. (NASDAQ:HSTO) rose 27.5% to close at $3.76 after gaining around 12% on Monday. The company, last month, announced a 1-for-20 reverse stock split.
    • Romeo Power, Inc. (NYSE:RMO) surged 26% to settle at $0.63. Romeo Power highlighted opening of new manufacturing center.
    • Lucira Health, Inc. (NASDAQ:LHDX) gained 24.3% to settle at $3.02.
    • Aclarion, Inc. (NASDAQ:ACON) jumped 22.9% to close at $1.01.
    • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) climbed 22.6% to close at $3.31. Blue Hat Interactive Entertainment Technology reported a registered direct offering of ordinary shares.
    • Kaspien Holdings Inc. (NASDAQ:KSPN) fell 22.5% to close at $5.28 after jumping around 162% on Monday.
    • NuCana plc (NASDAQ:NCNA) gained 21.1% to close at $0.9689. Regional Court of Dusseldorf has ruled in favor of NuCana, stating that Gilead Sciences Ireland UC and Gilead Sciences GmbH infringed NuCana's composition of matter claims in European Patent 2955190 through their sales of Sovaldi, Harvoni, Vosevi and Epclusa in Germany.
    • Alpha Teknova, Inc. (NASDAQ:TKNO) climbed 21.1% to settle at $9.20. Alpha Teknova recently filed for mixed shelf of up to $225 million.
    • SunLink Health Systems, Inc. (NYSE:SSY) rose 20.8% to close at $1.17.
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) gained 19% to close at $2.13. Eos Energy Enterprises recently announced the signing of two orders with Bridgelink Commodities and a Northeast solar developer totaling 1.1 GWh of energy storage capacity, and said its backlog is now over $460 million.
    • Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) surged 18.1% to settle at $1.50.
    • MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) rose 17.1% to close at $5.00.
    • Atara Biotherapeutics, Inc. (NASDAQ:ATRA) gained 17% to close at $8.66.
    • Atara Biotherapeutics reported completion of the ATA188 Phase 2 EMBOLD study interim analysis in patients with progressive MS.
    • Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) gained 15.7% to close at $3.40.
    • Indonesia Energy Corporation Limited (NYSE:INDO) rose 15.6% to close at $6.73 after the company announced it has discovered a potential natural gas bearing reservoir while drilling the Kruh-28 well.
    • InMode Ltd. (NASDAQ:INMD) gained 15.5% to close at $26.73 after the company issued Q2 EPS and sales guidance above analyst estimates. The company also raised its FY22 sales guidance above estimates.
    • Versus Systems Inc. (NASDAQ:VS) climbed 15.2% to close at $0.5415. Versus Systems, last month, received NASDAQ notification regarding minimum bid price deficiency.
    • Herbalife Nutrition Ltd. (NYSE:HLF) rose 15.2% to close at $22.70 after Jefferies upgraded the stock from Hold to Buy.
    • Versus Systems Inc. (NASDAQ:VS) jumped 15.2% to close at $0.5415.
    • A2Z Smart Technologies Corp. (NASDAQ:AZ) gained 15.2% to settle at $2.88.
    • Winc, Inc. (NYSE:WBEV) jumped 15.1% to close at $1.45.
    • Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) rose 15% to settle at $5.14. Aldeyra Therapeutics achieved the primary endpoints in a crossover clinical trial of 0.25% reproxalap ophthalmic solution, an investigational new drug candidate for dry eye disease.
    • Akanda Corp. (NASDAQ:AKAN) gained 14.7% to close at $0.90 after the company announced it will supply Tetra Bio-Pharma with pharmaceutical-grade cannabis for FDA trials of QIXLEEF.
    • GreenLight Biosciences Holdings (NASDAQ:GRNA) rose 13.7% to close at $2.32.
    • Westport Fuel Systems Inc. (NASDAQ:WPRT) climbed 12.9% to close at $1.14. Westport Fuel Systems was awarded €38 million program to supply LPG fuel systems to a global OEM.
    • American Airlines Group Inc. (NASDAQ:AAL) surged 10% to settle at $14.77 after the company said it expects Q2 revenue up 12% from 2019 levels.
    • Target Hospitality Corp. (NASDAQ:TH) gained 9.5% to close at $9.93.
    • United Airlines Holdings, Inc. (NASDAQ:UAL) rose 8.1% to settle at $38.23. Susquehanna maintained United Airlines Holdings with a Positive and lowered the price target from $60 to $43.
    • Carnival Corporation (NYSE:CCL) rose 7.5% to settle at $9.13 after the company's subsidiary Princess Cruises announced a new summer season of cruises roundtrip from Los Angeles in 2023.
    • The Boeing Company (NYSE:BA) gained 7.4% to close at $147.15. The company announced Q2 deliveries, including June deliveries of 51. The company also announced it delivered 216 jets in the first half of 2021.
    • Hawaiian Holdings, Inc. (NASDAQ:HA) gained 6.5% to close at $15.05. Susquehanna maintained Hawaiian Holdings with a Neutral and lowered the price target from $17 to $16.
    • Cosmos Holdings Inc. (NASDAQ:COSM) gained 6.4% to close at $0.4452. Cosmos Holdings said its subsidiary, Decahedron Ltd., has been granted full membership to the PAGB, a UK-based consumer healthcare association.
    • Delta Air Lines, Inc. (NYSE:DAL) rose 6.2% to settle at $31.09. Susquehanna maintained Delta Air Lines with a Positive and lowered the price target from $47 to $35.
    • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) rose 5.8% to close at $2.00. The company said it sees Q3 preliminary unaudited revenue to be in the range of $13.4 million to $13.9 million, a surge of around 463% to 484% year-over-year.

     

     

    Losers

    • United Maritime Corporation (NASDAQ:USEA) shares tumbled 38.3% to close at $4.37 on Tuesday.
    • VOXX International Corporation (NASDAQ:VOXX) shares fell 26.1% to close at $6.73 after the company posted a loss for the first quarter.
    • New Gold Inc. (NYSE:NGD) fell 26% to close at $0.7101 after the company cut its 2022 gold and copper production expectations.
    • Kaspien Holdings Inc. (NASDAQ:KSPN) dipped 22.5% to settle at $5.28 after the company announced the pricing of $8 million registered direct and private placement offerings.
    • Waitr Holdings Inc. (NASDAQ:WTRH) fell 21.1% to close at $0.3235 after jumping 17% on Monday. Waitr recently announced a new partnership with Burq to allow deliveries from several new retail industries.
    • Marrone Bio Innovations, Inc. (NASDAQ:MBII) dipped 20.2% to close at $0.7981. Marrone Bio Innovations’ shareholders recently approved merger agreement with Bioceres Crop Solutions Corp.
    • Endo International plc (NASDAQ:ENDP) dropped 19.7% to settle at $0.4097.
    • Hannon Armstrong Sustainable Infrastructure Capital, Inc. (NASDAQ:HASI) fell 19.1% to close at $29.41 after Muddy Waters Research issued a short report on the company.
    • ProMIS Neurosciences, Inc. (NASDAQ:PMN) fell 18.7% to close at $6.46.
    • Volcon, Inc. (NASDAQ:VLCN) dipped 18.3% to settle at $1.83. Volcon recently announced it has received thousands of non-binding pre-production orders for its fully electric UTV, the Stag.
    • Gaucho Group Holdings, Inc. (NASDAQ:VINO) dipped 18.2% to close at $0.4500.
    • Bioceres Crop Solutions Corp. (NASDAQ:BIOX) fell 18.1% to settle at $9.44.
    • Swvl Holdings Corp. (NASDAQ:SWVL) declined 17.8% to settle at $4.24.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) dropped 17% to settle at $0.3702.
    • Movano Inc. (NASDAQ:MOVE) fell 16.3% to settle at $2.5101.
    • LAVA Therapeutics N.V. (NASDAQ:LVTX) dipped 16.3% to close at $2.4201.
    • AeroClean Technologies, Inc. (NASDAQ:AERC) dropped 15.3% to close at $12.54.
    • COMSovereign Holding Corp. (NASDAQ:COMS) fell 15.1% to close at $0.1833.
    • SRAX, Inc. (NASDAQ:SRAX) dipped 15.1% to settle at $2.02.
    • Inpixon (NASDAQ:INPX) fell 14.9% to close at $0.1659 after gaining more than 6% on Monday.
    • Actelis Networks, Inc. (NASDAQ:ASNS) dropped 14.8% to close at $1.61.
    • Iterum Therapeutics plc (NASDAQ:ITRM) shares fell 14.5% to close at $0.2880. Iterum Therapeutics shares jumped 40% on Monday after the company announced that it has reached an agreement with the FDA under the special protocol assessment process on the design, endpoints and statistical analysis of a Phase 3 clinical trial for oral sulopenem etzadroxil-probenecid to begin in Q4.
    • Pliant Therapeutics, Inc. (NASDAQ:PLRX) dropped 13.2% to close at $19.97. Pliant Therapeutics commenced an underwritten public offering of $150 million.
    • MMTec, Inc. (NASDAQ:MTC) fell 13.1% to close at $0.1999. MMTEC, announced a 1-for-10 reverse stock split, effective July 13.
    • Forte Biosciences, Inc. (NASDAQ:FBRX) fell 13.1% to settle at $1.33.
    • Can-Fite BioPharma Ltd. (NYSE:CANF) dropped 12.9% to close at $0.88.
    • Assertio Holdings, Inc. (NASDAQ:ASRT) fell 12.8% to close at $2.8250.
    • ServiceNow, Inc. (NYSE:NOW) fell 12.7% to close at $427.94.
    • Stealth BioTherapeutics Corp (NASDAQ:MITO) fell 12.4% to settle at $0.2033 after the company announced receipt of non-compliance notice from NASDAQ.
    • Grove Collaborative Holdings, Inc. (NYSE:GROV) dropped 12.3% to close at $5.22.
    • Freshworks Inc. (NASDAQ:FRSH) fell 11.9% to close at $13.12.
    • E2open Parent Holdings, Inc. (NYSE:ETWO) fell 10.9% to close at $6.70 after the company reported financial results for its fiscal first quarter ended May 31, 2022.
    • DAVIDsTEA Inc. (NASDAQ:DTEA) dipped 10% to close at $1.17.
    • MultiPlan Corporation (NYSE:MPLN) fell 9.7% to close at $4.96. Goldman Sachs initiated coverage on MultiPlan with a Neutral rating and announced a price target of $6.5.
    • PriceSmart, Inc. (NASDAQ:PSMT) shares fell 9.5% to close at $65.54 as the company reported downbeat earnings for its third quarter.
    • Kiromic BioPharma, Inc. (NASDAQ:KRBP) fell 9% to settle at $0.4301 after dipping 16% on Monday. Kiromic BioPharma recently announced the timely completion of construction on its expanded current good manufacturing practice manufacturing facility in Houston.
    • Atlassian Corporation Plc (NASDAQ:TEAM) dropped 8.7% to close at $192.67.
    • Enphase Energy, Inc. (NASDAQ:ENPH) declined 8.1% to close at $189.47.
    • Paycom Software, Inc. (NYSE:PAYC) fell 7.2% to close at $296.80.
    • HubSpot, Inc. (NYSE:HUBS) dropped 6.5% to close at $273.34.
    • SKYX Platforms Corp. (NASDAQ:SKYX) slipped 5.6% to close at $2.69.
    • The Gap, Inc. (NYSE:GPS) shares fell 5% to close at $8.32 after the company announced a CEO transition and updated its second-quarter guidance. Gap announced that its president and CEO Sonia Syngal will step down from her position. The company also said that it expects second-quarter net sales to decline in approximately the high-single digit range, which is "relatively in line" with prior expectations.
    Get the next $AAL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAL
    $ADIL
    $AERC
    $AKAN

    CompanyDatePrice TargetRatingAnalyst
    Eos Energy Enterprises Inc.
    $EOSE
    2/27/2026$20.00Buy → Neutral
    Guggenheim
    Enphase Energy Inc.
    $ENPH
    2/25/2026$57.00Hold → Buy
    Jefferies
    Freshworks Inc.
    $FRSH
    2/23/2026$8.00Buy → Hold
    Jefferies
    Rhythm Pharmaceuticals Inc.
    $RYTM
    2/19/2026$478.00Outperform
    RBC Capital Mkts
    HA Sustainable Infrastructure Capital Inc.
    $HASI
    2/17/2026$40.00 → $50.00Buy
    TD Cowen
    Paycom Software Inc.
    $PAYC
    2/12/2026$175.00 → $137.00Market Perform
    BMO Capital Markets
    Atlassian Corporation
    $TEAM
    2/6/2026$135.00 → $130.00Outperform
    BMO Capital Markets
    Enphase Energy Inc.
    $ENPH
    2/4/2026$52.00Hold → Buy
    HSBC Securities
    More analyst ratings

    $AAL
    $ADIL
    $AERC
    $AKAN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    First Towers & Fiber Corp. Owns the Largest Dark Fiber Network in Central Mexico

    Toronto, Ontario--(Newsfile Corp. - February 27, 2026) - Akanda Corp. (NASDAQ:AKAN) ("Akanda") and its 100% owned subsidiary First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, announced today plans to further expand the leasing of its approximately 700-kilometre dark fiber optic network located in Central Mexico. The network represents the largest dark fiber infrastructure in the region, serving several of Mexico's most active industrial corridors and fastest-growing state economies.The network was constructed following the execution of a 20-year long-term dark fiber lease agreement with Telefónica, the Spanish multinationa

    2/27/26 8:30:00 AM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    Sunrun Reports Fourth Quarter and Full Year 2025 Financial Results

    Net change in cash and restricted cash of $290 million and Cash Generation1 of $377 million in 2025 Outlook for positive Cash Generation2 in the range of $250 million to $450 million for full year 2026 Aggregate Subscriber Value of $1.3 billion in Q4 Contracted Net Value Creation of $176 million in Q4, or $0.76 per share Storage Attachment Rate reached record 71% in Q4 Paid down $81 million of recourse debt in Q4 with excess cash SAN FRANCISCO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Sunrun (NASDAQ:RUN), America's largest provider of home battery storage, solar, and home-to-grid power plants, today announced financial results for the fourth quarter and full year ended December 31, 2025. "

    2/26/26 4:01:00 PM ET
    $HASI
    $NRG
    $PCG
    Finance/Investors Services
    Finance
    Electric Utilities: Central
    Utilities

    Teknova Reports Fourth Quarter and Full Year 2025 Financial Results

    Full year 2025 total revenue was $40.5 million, up 7% year-over-year and in line with guidanceFourth quarter 2025 total revenue was $10.0 million, up 8% over the same quarter prior yearCompany provides 2026 revenue guidance of $42-44 million HOLLISTER, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. ("Teknova" or the "Company") (NASDAQ:TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced financial results for the fourth quarter and full year ended December 31, 2025. "After another successful year of disciplined execution against our strategic objectives,

    2/26/26 4:01:00 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $AAL
    $ADIL
    $AERC
    $AKAN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by President Levy Robert

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    2/27/26 8:37:14 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    SEC Form 4 filed by Chief Commercial Officer Lamberti Frank

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    2/27/26 8:35:20 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    Executive Chairman Johnson Michael was granted 72,689 shares, increasing direct ownership by 9% to 887,415 units (SEC Form 4)

    4 - HERBALIFE LTD. (0001180262) (Issuer)

    2/27/26 8:33:50 PM ET
    $HLF
    Other Pharmaceuticals
    Health Care

    $AAL
    $ADIL
    $AERC
    $AKAN
    SEC Filings

    View All

    SEC Form S-8 filed by Aldeyra Therapeutics Inc.

    S-8 - Aldeyra Therapeutics, Inc. (0001341235) (Filer)

    2/27/26 5:07:16 PM ET
    $ALDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Aldeyra Therapeutics Inc.

    10-K - Aldeyra Therapeutics, Inc. (0001341235) (Filer)

    2/27/26 4:47:10 PM ET
    $ALDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HA Sustainable Infrastructure Capital Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement

    8-K - HA Sustainable Infrastructure Capital, Inc. (0001561894) (Filer)

    2/27/26 4:33:53 PM ET
    $HASI
    Finance/Investors Services
    Finance

    $AAL
    $ADIL
    $AERC
    $AKAN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $120,000 worth of shares (291,262 units at $0.41), increasing direct ownership by 4% to 8,473,382 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/12/26 2:20:08 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    President & CEO Kothandaraman Badrinarayanan bought $259,884 worth of shares (5,000 units at $51.98) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/5/26 4:41:25 PM ET
    $ENPH
    Semiconductors
    Technology

    $AAL
    $ADIL
    $AERC
    $AKAN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Eos Energy downgraded by Guggenheim with a new price target

    Guggenheim downgraded Eos Energy from Buy to Neutral and set a new price target of $20.00

    2/27/26 8:28:11 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Enphase Energy upgraded by Jefferies with a new price target

    Jefferies upgraded Enphase Energy from Hold to Buy and set a new price target of $57.00

    2/25/26 7:19:45 AM ET
    $ENPH
    Semiconductors
    Technology

    Freshworks downgraded by Jefferies with a new price target

    Jefferies downgraded Freshworks from Buy to Hold and set a new price target of $8.00

    2/23/26 8:31:21 AM ET
    $FRSH
    Computer Software: Prepackaged Software
    Technology

    $AAL
    $ADIL
    $AERC
    $AKAN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

    For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

    11/9/23 2:30:20 PM ET
    $SRAX
    $SNAP
    Advertising
    Consumer Discretionary
    Computer Software: Programming Data Processing
    Technology

    $AAL
    $ADIL
    $AERC
    $AKAN
    Leadership Updates

    Live Leadership Updates

    View All

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    United Gives MileagePlus Credit Cardholders More Miles, Exclusive Flight Discounts

    MileagePlus members with a credit, debit or Chase co-branded card can soon earn up to twice as many miles for United flights as non-cardholders, get at least 10% off award tickets and access to exclusive Saver Award faresUnited now offers its most loyal members who have a United card some of the richest rewards among airline or travel credit card programsCHICAGO, Feb. 19, 2026 /PRNewswire/ -- United Airlines is giving travelers three new reasons to hold and use a United MileagePlus® credit or debit card: the ability to earn up to twice as many miles as non-cardholders, at least 10% off United award tickets and access to special inventory of its lowest-priced award seats.

    2/19/26 8:00:00 AM ET
    $UAL
    Air Freight/Delivery Services
    Consumer Discretionary

    Atlassian Appoints James Chuong as Chief Financial Officer

    Atlassian Corporation (NASDAQ:TEAM), a leading provider of team collaboration and productivity software, today announced the appointment of James Chuong as Chief Financial Officer (CFO), effective March 30, 2026. As CFO, James will oversee Atlassian's Finance and Legal teams, bringing more than 20 years of finance leadership experience across the technology and investment banking sectors. Most recently, James served as Chief Financial Officer at LinkedIn, where he led the company's financial operations and helped guide it to more than 1 billion members and $18 billion in revenue. During his 13 years at LinkedIn, he held several finance leadership roles, leading global teams responsible

    2/18/26 5:15:00 PM ET
    $TEAM
    Computer Software: Prepackaged Software
    Technology

    $AAL
    $ADIL
    $AERC
    $AKAN
    Financials

    Live finance-specific insights

    View All

    Sunrun Reports Fourth Quarter and Full Year 2025 Financial Results

    Net change in cash and restricted cash of $290 million and Cash Generation1 of $377 million in 2025 Outlook for positive Cash Generation2 in the range of $250 million to $450 million for full year 2026 Aggregate Subscriber Value of $1.3 billion in Q4 Contracted Net Value Creation of $176 million in Q4, or $0.76 per share Storage Attachment Rate reached record 71% in Q4 Paid down $81 million of recourse debt in Q4 with excess cash SAN FRANCISCO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Sunrun (NASDAQ:RUN), America's largest provider of home battery storage, solar, and home-to-grid power plants, today announced financial results for the fourth quarter and full year ended December 31, 2025. "

    2/26/26 4:01:00 PM ET
    $HASI
    $NRG
    $PCG
    Finance/Investors Services
    Finance
    Electric Utilities: Central
    Utilities

    Teknova Reports Fourth Quarter and Full Year 2025 Financial Results

    Full year 2025 total revenue was $40.5 million, up 7% year-over-year and in line with guidanceFourth quarter 2025 total revenue was $10.0 million, up 8% over the same quarter prior yearCompany provides 2026 revenue guidance of $42-44 million HOLLISTER, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. ("Teknova" or the "Company") (NASDAQ:TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced financial results for the fourth quarter and full year ended December 31, 2025. "After another successful year of disciplined execution against our strategic objectives,

    2/26/26 4:01:00 PM ET
    $TKNO
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update

    -- Fourth quarter 2025 net product revenue from global sales of IMCIVREE® (setmelanotide) of $57.3 million -- -- March 20, 2026 PDUFA goal date for sNDA for setmelanotide in acquired hypothalamic obesity (HO) ---- Phase 2 open-label extension data showed bivamelagon achieved persistent BMI reductions at six and nine months; Completed positive end-of-Phase-2 meeting with FDA ---- On track to report topline data from 12-patient Japanese cohort of setmelanotide Phase 3 trial in acquired HO in March 2026 -- -- On track to report topline data from Phase 3 EMANATE trial evaluating setmelanotide in rare genetically caused melanocortin-4 receptor (MC4R) pathway diseases in March 2026 -- -- Manag

    2/26/26 7:00:00 AM ET
    $RYTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAL
    $ADIL
    $AERC
    $AKAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by 51Talk Online Education Group

    SC 13D/A - 51Talk Online Education Group (0001659494) (Subject)

    12/17/24 4:07:04 PM ET
    $COE
    Other Consumer Services
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13D/A filed by Paycom Software Inc.

    SC 13D/A - Paycom Software, Inc. (0001590955) (Subject)

    12/13/24 7:06:11 PM ET
    $PAYC
    Computer Software: Prepackaged Software
    Technology

    $AAL
    $ADIL
    $AERC
    $AKAN
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Assertio Holdings Inc. on Jun 6

    Recent insider transactions at Assertio Holdings Inc. have brought attention to the company's stock activity. On June 6, 2024, Mason Heather L purchased $24,250 worth of shares, acquiring 25,000 units at $0.97 per share. This transaction increased Mason Heather L's direct ownership by 13% to 212,650 units, as reported in the SEC Form 4. Several other notable insider transactions have taken place at Assertio Holdings Inc. leading up to this purchase. Patel Ajay, Schwichtenberg Paul, and Schlessinger Sam all converted options into shares and covered exercise/tax liability by utilizing their shares. These transactions resulted in ownership increases of 16%, 20%, and 21%, respectively. Addition

    6/10/24 1:20:50 AM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care